Advair hfa and Infusion site swelling - a phase IV clinical study of FDA data

Summary:

Infusion site swelling is reported as a side effect among people who take Advair hfa (fluticasone propionate; salmeterol xinafoate), especially for people who are female, 60+ old, also take Epinephrine, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Infusion site swelling when taking Advair hfa. It is created by eHealthMe based on reports of 69,236 people who have side effects when taking Advair hfa from the FDA, and is updated regularly.

What is Advair hfa?

Advair hfa has active ingredients of fluticasone propionate; salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 69,790 Advair hfa users. Check the latest studies of Advair hfa.

What is Infusion site swelling?

Infusion site swelling is found to be associated with 579 drugs and 359 conditions by eHealthMe. Check the latest studies of Infusion site swelling.

On Jul, 19, 2026

69,236 people reported to have side effects when taking Advair hfa.
Among them, 147 people (0.21%) have Infusion site swelling.

Could Advair hfa cause Infusion site swelling?

Among these 147 people:

What is the gender of people who have Infusion site swelling when taking Advair hfa? *

Click here to view

What is the age of people who have Infusion site swelling when taking Advair hfa? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Advair hfa and have Infusion site swelling?

- Check whether Infusion site swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Advair hfa:

Advair hfa (69,790 reports)

Infusion site swelling treatments and more:

Infusion site swelling (6,559 reports)

How severe was Infusion site swelling and when was it recovered:

Infusion site swelling in Advair hfa

Expand to all the drugs that have ingredients of fluticasone propionate; salmeterol xinafoate:

Infusion site swelling and drugs with ingredients of fluticasone propionate; salmeterol xinafoate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Advair hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infusion site swelling:

Infusion site swelling (579 drugs)

Browse all the conditions that are associated with Infusion site swelling:

Infusion site swelling (359 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone propionate; salmeterol xinafoate (the active ingredients of Advair hfa) and Advair hfa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.